Overactive bladder syndrome

Indication for Fesoterodine

Population group: Suitable for both men and women, only adults (18 years old or older)
Therapeutic intent: Curative procedure

Fesoterodine is indicated in adults for treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur with overactive bladder syndrome.

For this indication, competent medicine agencies globally authorize below treatments:

4-8 mg once daily

For: Adults (18-64) Elders (65+)

Dosage regimens

Oral, between 4 and 8 milligrams, once daily.

Detailed description

The recommended starting dose is 4 mg once daily. Based upon individual response, the dose may be increased to 8 mg once daily. The maximum daily dose is 8 mg.

Full treatment effect was observed between 2 and 8 weeks. Hence, it is recommended to reevaluate the efficacy for the individual patient after 8 weeks of treatment.

Dosage considerations

Fesoterodine tablets are to be taken once daily with liquid and swallowed whole. Fesoterodine can be administered with or without food.

Active ingredient

Fesoterodine is a competitive, specific muscarinic receptor antagonist. It is rapidly and extensively hydrolysed by non-specific plasma esterases to the 5-hydroxymethyl derivative, its primary active metabolite, which is the main active pharmacological principle of fesoterodine.

Read more about Fesoterodine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner